Iovance Biotherapeutics Stock (NASDAQ: IOVA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 58.023K / 8.978M |
Day Range | - - - |
52 Wk Range | 3.210 - 18.330 |
Market Cap | $3.134B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 19.53% |
Days to Cover | 10.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Iovance Biotherapeutics (NASDAQ: IOVA) through any online brokerage.
Other companies in Iovance Biotherapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for Iovance Biotherapeutics (NASDAQ: IOVA) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 32.00 expecting IOVA to rise to within 12 months (a possible 185.71% upside). 43 analyst firms have reported ratings in the last year.
The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $11.2 last updated Today at May 13, 2024 at 9:17 AM EDT.
There are no upcoming dividends for Iovance Biotherapeutics.
Iovance Biotherapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Iovance Biotherapeutics.
Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.